The AHA today urged the Centers for Medicare & Medicaid Services to suspend the pain-related questions in the Value-Based Purchasing Program while the agency works to address concerns the questions may inadvertently contribute to the opioid epidemic. The three questions are part of the Hospital Consumer Assessment of Healthcare Providers and Services. “The AHA agrees that the HCAHPS survey should inquire about pain management, that performance scores should be publicly reported, and that redesigned pain questions should eventually be reincorporated into the VBP program,” wrote Ashley Thompson, AHA senior vice president of public policy analysis and development. “However, we also want to ensure that the questions do not create pressure to prescribe opioids or other prescription painkillers or punish providers who, in their best judgment, choose not to prescribe them.”

Headline
The Centers for Medicare & Medicaid Services is seeking comments by May 11 on its proposed revisions to data reporting requirements for Medicare Advantage…
Headline
The Medicare Payment Advisory Commission March 12 released its March 2026 report to Congress, which includes its recommended payment rates for hospital…
Headline
The Centers for Medicare & Medicaid Services March 11 issued guidance to state survey agency directors clarifying and reinforcing the roles and…
Headline
The Joint Economic Committee March 10 released a report that found Medicare Part B premiums rose last year due to Medicare Advantage overpayments. The…
Headline
March 8-14 marks Patient Safety Awareness Week. The AHA has several resources including podcasts, videos and reports that show how AHA members are advancing…
Headline
The U.S. District Court for the Southern District of Florida March 6 ruled in favor of five Florida hospitals in a case challenging the methodology used by the…